Resistance to cetuximab – implication of PTEN expression in the cellular sensitivity to cetuximab (Erbitux®) of Head and Neck Squamous Cell Carcinoma (HNSCC)
Mriouah, J, Chartier, C, Boura, C, Fifre, A, Fries, I, Ramacci, C, Merlin, J.L, Faivre, B.M.A
Published in European journal of cancer supplements (01.07.2008)
Published in European journal of cancer supplements (01.07.2008)
Get full text
Journal Article